Evidence map›Paper›PMID 36516777›Full record

ArticleCell reports2022

A specific type of Argonaute phosphorylation regulates binding to microRNAs during C. elegans development.

Miguel Quévillon Huberdeau, Vivek Nilesh Shah, Smita Nahar, Julia Neumeier, François Houle, Astrid Bruckmann, Foivos Gypas, Kotaro Nakanishi, Helge Großhans, Gunter Meister and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Miguel Quévillon HuberdeauCHU de Québec-Université Laval Research Center (Oncology Division), Québec City, QC G1R 3S3, Canada; Université Laval Cancer Research Centre, Québec City, QC G1R 3S3, Canada.
Vivek Nilesh ShahCHU de Québec-Université Laval Research Center (Oncology Division), Québec City, QC G1R 3S3, Canada; Université Laval Cancer Research Centre, Québec City, QC G1R 3S3, Canada.
Smita NaharFriedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
Julia NeumeierRegensburg Center for Biochemistry (RCB), Laboratory for RNA Biology, University of Regensburg, 93053 Regensburg, Germany.
François HouleCHU de Québec-Université Laval Research Center (Oncology Division), Québec City, QC G1R 3S3, Canada; Université Laval Cancer Research Centre, Québec City, QC G1R 3S3, Canada.
Astrid BruckmannRegensburg Center for Biochemistry (RCB), Laboratory for RNA Biology, University of Regensburg, 93053 Regensburg, Germany.
Foivos GypasFriedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
Kotaro NakanishiDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA; Center for RNA Biology, Columbus, OH 43210, USA.
Helge GroßhansFriedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; University of Basel, 4056 Basel, Switzerland.
Gunter MeisterRegensburg Center for Biochemistry (RCB), Laboratory for RNA Biology, University of Regensburg, 93053 Regensburg, Germany.
Martin J SimardCHU de Québec-Université Laval Research Center (Oncology Division), Québec City, QC G1R 3S3, Canada; Université Laval Cancer Research Centre, Québec City, QC G1R 3S3, Canada. Electronic address: martin.simard@crchudequebec.ulaval.ca.
Université Laval · CAUniversity of Regensburg · DEFriedrich Miescher Institute · CHColumbus Center · USUniversity of Basel · CH

Funding

Target specificity of human RNA-induced silencing complexR01GM124320 · NIGMS · OHIO STATE UNIVERSITY · PI NAKANISHI, KOTARO · 2017 to 2025
$3.1M
NIGMS NIH HHS R01 GM124320
6 · The paper itself

Abstract

Argonaute proteins are at the core of the microRNA-mediated gene silencing pathway essential for animals. In C. elegans, the microRNA-specific Argonautes ALG-1 and ALG-2 regulate multiple processes required for proper animal developmental timing and viability. Here we identified a phosphorylation site on ALG-1 that modulates microRNA association. Mutating ALG-1 serine 642 into a phospho-mimicking residue impairs microRNA binding and causes embryonic lethality and post-embryonic phenotypes that are consistent with alteration of microRNA functions. Monitoring microRNA levels in alg-1 phosphorylation mutant animals shows that microRNA passenger strands increase in abundance but are not preferentially loaded into ALG-1, indicating that the miRNA binding defects could lead to microRNA duplex accumulation. Our genetic and biochemical experiments support protein kinase A (PKA) KIN-1 as the putative kinase that phosphorylates ALG-1 serine 642. Our data indicate that PKA triggers ALG-1 phosphorylation to regulate its microRNA association during C. elegans development.

Indexed as

Caenorhabditis elegans ProteinsMicroRNAsAnimalsArgonaute ProteinsCaenorhabditis elegansPhosphorylationRNA-Binding ProteinsSerineALG-1 protein, C elegansALG-2 protein, C elegansArgonaute ProteinsCaenorhabditis elegans ProteinsMicroRNAsRNA-Binding ProteinsSerineAGOALG-1CP: Developmental biologyCP: Molecular biologygene regulationKIN-1microRNA duplexmicroRNA passenger strandmiRISCPKApost-translational modificationprotein kinase A

Identifiers

PMID36516777
PMCPMC10436268
OpenAlexW4311309897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.